![Partnership to Promote Multi-Ancestry PRS Breast Cancer Testing](https://www.g2intelligence.com/wp-content/uploads/2023/02/March23.LIR_.DXDeals-iStock-1800x1250-1-1080x675.jpg)
Partnership to Promote Multi-Ancestry PRS Breast Cancer Testing
Genomics software developer Allelica to collaborate with Taiwanese precision medicine firm to develop a multi-ancestry breast cancer test.
Genomics software developer Allelica to collaborate with Taiwanese precision medicine firm to develop a multi-ancestry breast cancer test.
Researchers found that combining AI with both imaging technologies can improve the detection of cancer in women with dense breasts.
A new method for early detection of 14 cancer types based on glycosaminoglycan profiles shows promise.
A new method of early, multi-cancer detection could prove more effective for non-invasive screening than other emerging options.
While AI as a diagnostic tool is still years away from regular clinical use, recent research is an important step.